|
1
|
Razzaghi H, Quesnel-Crooks S, Sherman R,
Joseph R, Kohler B, Andall-Brereton G, Ivey MA, Edwards BK, Mery L,
Gawryszewski V and Saraiya M: Leading causes of cancer
mortality-Caribbean region, 2003–2013. MMWR Morb Mortal Wkly Rep.
65:1395–1400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manson MM: Cancer prevention-the potential
for diet to modulate molecular signalling. Trends Mol Med. 9:11–18.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang SF, Wang XL, Yang XQ and Chen N:
Autophagy-associated targeting pathways of natural products during
cancer treatment. Asian Pac J Cancer Prev. 15:10557–10563. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kou X, Kirberger M, Yang Y and Chen N:
Natural products for cancer prevention associated with Nrf2-ARE
pathway. Food Science and Human Wellness. 2:22–28. 2013. View Article : Google Scholar
|
|
5
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Kok TM, van Breda SG and Manson MM:
Mechanisms of combined action of different chemopreventive dietary
compounds: A review. Eur J Nutr. 47 Suppl 2:S51–S59. 2008.
View Article : Google Scholar
|
|
7
|
Chen D and Dou QP: Tea polyphenols and
their roles in cancer prevention and chemotherapy. Int J Mol Sci.
9:1196–1206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang CS, Ju J, Lu G, Xiao H, Hao X, Sang S
and Lambert JD: Cancer prevention by tea and tea polyphenols. Asia
Pac J Clin Nutr. 17 Suppl 1:S245–S248. 2008.
|
|
9
|
Fimognari C, Lenzi M and Hrelia P:
Chemoprevention of cancer by isothiocyanates and anthocyanins:
Mechanisms of action and structure-activity relationship. Curr Med
Chem. 15:440–447. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Udenigwe CC and Aluko RE: Food
protein-derived bioactive peptides: Production, processing, and
potential health benefits. J Food Sci. 77:R11–R14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia S, Du Z, Jiang H, Huang X, Chen Z and
Chen N: Daintain/AIF-1 accelerates the activation of insulin-like
growth factor-1 receptor signaling pathway in HepG2 cells. Oncol
Rep. 34:511–517. 2015.PubMed/NCBI
|
|
12
|
Bhutia SK and Maiti TK: Targeting tumors
with peptides from natural sources. Trends Biotechnol. 26:210–217.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Mejia EG and Dia VP: The role of
nutraceutical proteins and peptides in apoptosis, angiogenesis and
metastasis of cancer cells. Cancer Metastasis Rev. 29:511–528.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Jia SH, Kirberger M and Chen N:
Lunasin as a promising health-beneficial peptide. Eur Rev Med
Pharmacol Sci. 18:2070–2075. 2014.PubMed/NCBI
|
|
15
|
McCue P and Shetty K: Health benefits of
soy isoflavonoids and strategies for enhancement: A review. Crit
Rev Food Sci Nutr. 44:361–367. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Woo HD, Park S, Oh K, Kim HJ, Shin HR,
Moon HK and Kim J: Diet and cancer risk in the Korean population: A
meta- analysis. Asian Pac J Cancer Prev. 15:8509–8519. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chi F, Wu R, Zeng YC, Xing R, Liu Y and Xu
ZG: Post-diagnosis soy food intake and breast cancer survival: A
meta-analysis of cohort studies. Asian Pac J Cancer Prev.
14:2407–2412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee MM, Gomez SL, Chang JS, Wey M, Wang RT
and Hsing AW: Soy and isoflavone consumption in relation to
prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev.
12:665–668. 2003.PubMed/NCBI
|
|
19
|
Yamamoto S, Sobue T, Kobayashi M, Sasaki S
and S; Japan Public Health Center-Based Prospective Study on Cancer
Cardiovascular Diseases G Tsugane: Soy, isoflavones, and breast
cancer risk in Japan. J Natl Cancer Inst. 95:906–913. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Messina M and Barnes S: The role of soy
products in reducing risk of cancer. J Natl Cancer Inst.
83:541–546. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toyomura K and Kono S: Soybeans, soy
foods, isoflavones and risk of colorectal cancer: A review of
experimental and dpidemiological data. Asian Pac J Cancer Prev.
3:125–132. 2002.PubMed/NCBI
|
|
22
|
Clemente A and Mdel C Arques: Bowman-Birk
inhibitors from legumes as colorectal chemopreventive agents. World
J Gastroenterol. 20:10305–10315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galvez AF and de Lumen BO: A soybean cDNA
encoding a chromatin-binding peptide inhibits mitosis of mammalian
cells. Nat Biotechnol. 17:495–500. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jeong HJ, Jeong JB, Kim DS, Park JH, Lee
JB, Kweon DH, Chung GY, Seo EW and de Lumen BO: The cancer
preventive peptide lunasin from wheat inhibits core histone
acetylation. Cancer Lett. 255:42–48. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong HJ, Lee JR, Jeong JB, Park JH,
Cheong YK and de Lumen BO: The cancer preventive seed peptide
lunasin from rye is bioavailable and bioactive. Nutr Cancer.
61:680–686. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Mejia E Gonzalez, Vásconez M, de Lumen
BO and Nelson R: Lunasin concentration in different soybean
genotypes, commercial soy protein, and isoflavone products. J Agric
Food Chem. 52:5882–5887. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeong HJ, Lam Y and de Lumen BO: Barley
lunasin suppresses ras-induced colony formation and inhibits core
histone acetylation in mammalian cells. J Agric Food Chem.
50:5903–5908. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jeong HJ, Park JH, Lam Y and de Lumen BO:
Characterization of lunasin isolated from soybean. J Agric Food
Chem. 51:7901–7906. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rizzello CG, Nionelli L, Coda R and
Gobbetti M: Synthesis of the cancer preventive peptide lunasin by
lactic acid bacteria during sourdough fermention. Nutr Cancer.
64:111–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guijarro-Díez M, García MC, Crego AL and
Marina ML: Off-line two dimensional isoelectrofocusing-liquid
chromatography/mass spectrometry (time of flight) for the
determination of the bioactive peptide lunasin. J Chromatogr A.
1371:117–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsieh CC, Hernándz-Ledesma B, Jeong HJ,
Park JH and de Lumen BO: Complementary roles in cancer prevention:
Protease inhibitor makes the cancer preventive peptide lunasin
bioavailable. PLoS One. 5:e88902010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jeong JB, Jeong HJ, Park JH, Lee SH, Lee
JR, Lee HK, Chung GY, Choi JD and de Lumen BO: Cancer-preventive
peptide lunasin from Solanum nigrum L. inhibits acetylation of core
histones H3 and H4 and phosphorylation of retinoblastoma protein
(Rb). J Agric Food Chem. 55:10707–10713. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dia VP, Torres S, de Lumen BO, Erdman JW
Jr and De Mejia EG: Presence of lunasin in plasma of men after soy
protein consumption. J Agric Food Chem. 57:1260–1266. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park JH, Jeong HJ and Lumen BO: In vitro
digestibility of the cancer-preventive soy peptides lunasin and
BBI. J Agric Food Chem. 55:10703–10706. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang Q, Pan Y, Cheng Y and Li H, Liu D
and Li H: Lunasin suppresses the migration and invasion of breast
cancer cells by inhibiting matrix metalloproteinase-2/-9 via the
FAK/Akt/ERK and NF-kB signaling pathways. Oncol Rep. 36:253–262.
2016.PubMed/NCBI
|
|
36
|
Hsieh CC, Hernandez-Ledesma B and de Lumen
BO: Soybean peptide lunasin suppresses in vitro and in vivo
7,12-dimethylbenz[a]anthracene-induced tumorigenesis. J Food Sci.
75:H311–H316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsieh CC, Hernandez-Ledesma B and de Lumen
BO: Lunasin-aspirin combination against NIH/3T3 cells
transformation induced by chemical carcinogens. Plant Foods Hum
Nutr. 66:107–113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hernandez-Ledesma B, Hsieh CC and de Lumen
BO: Relationship between lunasin's sequence and its inhibitory
activity of histones H3 and H4 acetylation. Mol Nutr Food Res.
55:989–998. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsieh CC, Hernandez-Ledesma B and de Lumen
BO: Lunasin, a novel seed peptide, sensitizes human breast cancer
MDA-MB-231 cells to aspirin-arrested cell cycle and induced
apoptosis. Chem Biol Interact. 186:127–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang W, Bringe NA, Berhow MA and de Mejia
E Gonzalez: beta-Conglycinins among sources of bioactives in
hydrolysates of different soybean varieties that inhibit leukemia
cells in vitro. J Agric Food Chem. 56:4012–4020. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
de Mejia EG, Wang W and Dia VP: Lunasin,
with an arginine-glycine-aspartic acid motif, causes apoptosis to
L1210 leukemia cells by activation of caspase-3. Mol Nutr Food Res.
54:406–414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Galvez AF, Chen N, Macasieb J and de Lumen
BO: Chemopreventive property of a soybean peptide (lunasin) that
binds to deacetylated histones and inhibits acetylation. Cancer
Res. 61:7473–7478. 2001.PubMed/NCBI
|
|
43
|
Hsieh EA, Chai CM, de Lumen BO, Neese RA
and Hellerstein MK: Dynamics of keratinocytes in vivo using HO
labeling: A sensitive marker of epidermal proliferation state. J
Invest Dermatol. 123:530–536. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dwarakanath BS, Verma A, Bhatt AN, Parmar
VS and Raj HG: Targeting protein acetylation for improving cancer
therapy. Indian J Med Res. 128:13–21. 2008.PubMed/NCBI
|
|
45
|
Dalvai M and Bystricky K: The role of
histone modifications and variants in regulating gene expression in
breast cancer. J Mammary Gland Biol Neoplasia. 15:19–33. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Strahl BD and Allis CD: The language of
covalent histone modifications. Nature. 403:41–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Muraoka M, Konishi M, Kikuchi-Yanoshita R,
Tanaka K, Shitara N, Chong JM, Iwama T and Miyaki M: p300 gene
alterations in colorectal and gastric carcinomas. Oncogene.
12:1565–1569. 1996.PubMed/NCBI
|
|
48
|
Gayther SA, Batley SJ, Linger L, Bannister
A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, et
al: Mutations truncating the EP300 acetylase in human cancers. Nat
Genet. 24:300–303. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ionov Y, Matsui S and Cowell JK: A role
for p300/CREB binding protein genes in promoting cancer progression
in colon cancer cell lines with microsatellite instability. Proc
Natl Acad Sci USA. 101:pp. 1273–1278. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jeong HJ, Jeong JB, Kim DS and de Lumen
BO: Inhibition of core histone acetylation by the cancer preventive
peptide lunasin. J Agric Food Chem. 55:632–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hernandez-Ledesma B and de Lumen BO:
Lunasin: A novel cancer preventive seed Peptide. Perspect Medicin
Chem. 2:75–80. 2008.PubMed/NCBI
|
|
52
|
Frolov MV and Dyson NJ: Molecular
mechanisms of E2F-dependent activation and pRB-mediated repression.
J Cell Sci. 117:2173–2181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
de Lumen BO: Lunasin: A novel cancer
preventive seed peptide that modifies chromatin. J AOAC Int.
91:932–935. 2008.PubMed/NCBI
|
|
54
|
Kuper H, Adami HO and Trichopoulos D:
Infections as a major preventable cause of human cancer. J Intern
Med. 248:171–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Allavena P, Garlanda C, Borrello MG, Sica
A and Mantovani A: Pathways connecting inflammation and cancer.
Curr Opin Genet Dev. 18:3–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Villegas I, Sanchez-Fidalgo S and Alarcón
de la Lastra C: New mechanisms and therapeutic potential of
curcumin for colorectal cancer. Mol Nutr Food Res. 52:1040–1061.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hernandez-Ledesma B, Hsieh CC and de Lumen
BO: Antioxidant and anti-inflammatory properties of cancer
preventive peptide lunasin in RAW 264.7 macrophages. Biochem
Biophys Res Commun. 390:803–808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jia S, Zhang S, Yuan H and Chen N: Lunasin
inhibits cell proliferation via apoptosis and reduces the
production of proinflammatory cytokines in cultured rheumatoid
arthritis synovial fibroblasts. Biomed Res Int. 2015:3468392015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang W, Dia VP, Vasconez M, de Mejia EG
and Nelson RL: Analysis of soybean protein-derived peptides and the
effect of cultivar, environmental conditions, and processing on
lunasin concentration in soybean and soy products. J AOAC Int.
91:936–946. 2008.PubMed/NCBI
|
|
60
|
Jeong JB, De Lumen BO and Jeong HJ:
Lunasin peptide purified from Solanum nigrum L. protects DNA from
oxidative damage by suppressing the generation of hydroxyl radical
via blocking fenton reaction. Cancer Lett. 293:58–64. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Jacobo-Herrera NJ, Pérez-Plasencia C,
Camacho-Zavala E, González GF, Urrutia EL, García-Castillo V and
Zentella-Dehesa A: Clinical evidence of the relationship between
aspirin and breast cancer (review). Oncol Rep.
32:4512014.PubMed/NCBI
|
|
62
|
Giovannucci E and Chan AT: Role of vitamin
and mineral supplementation and aspirin use in cancer survivors. J
Clin Oncol. 28:4081–4085. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Laine L: Review article: Gastrointestinal
bleeding with low-dose aspirin-what's the risk? Aliment Pharmacol
Ther. 24:897–908. 2006. View Article : Google Scholar : PubMed/NCBI
|
